Established in 2024 as a part of Scripps Research, Lightner Lab is dedicated to studying inflammatory bowel disease (IBD), a condition that is increasingly prevalent worldwide, now impacting 1 in 100 individuals in the United States. Despite many...

Lightner Lab: Leading the Charge in Advancing IBD Treatments
read more